BFRI

Biofrontera Inc

• Seeking Alpha·6d ago

  Biofrontera GAAP EPS of -$0.05, revenue of $12M

• NASDAQ·6d ago

  Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates

• Dow Jones·6d ago

  *Biofrontera 2Q Loss/Shr 5c >BFRI

• Dow Jones·6d ago

  *Biofrontera 2Q Net Product Rev $12.0M >BFRI

• NASDAQ·08/07 12:20

  Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates

• TipRanks·07/08 16:31

  Biofrontera’s Acne PDT Trial Completion: What Investors Should Watch Next

• TipRanks·07/07 16:30

  Biofrontera’s Phase III Actinic Keratosis Study Nears Data Payoff for Investors

• TipRanks·06/17 21:29

  Biofrontera Shareholders Approve Director Elections and Equity Plan

• TipRanks·06/03 00:15

  Biofrontera Earnings Call Highlights Growth And Risks

• TipRanks·05/19 13:35

  StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls

• Dow Jones·05/19 12:51

  Biofrontera Price Target Maintained With a $3.00/Share by Benchmark

• Dow Jones·05/19 12:51

  Biofrontera Cut to Speculative Buy From Buy by Benchmark

• TipRanks·05/19 10:15

  Biofrontera downgraded to Speculative Buy from Buy at Benchmark

• TipRanks·05/18 06:30

  Analysts Are Bullish on These Healthcare Stocks: Biofrontera (BFRI), MiNK Therapeutics (INKT)

• Seeking Alpha·05/14 19:40

  Biofrontera GAAP EPS of -$0.41 misses by $0.33, revenue of $10.1M misses by $0.4M